Recent strategies to identify broadly neutralizing antibodies against influenza A virus.
Recent technologies have made it possible to efficiently identify several broadly cross-neutralizing antibodies against the hemagglutinin of influenza A virus. With these advances comes a potential new age in influenza virus vaccine development and the possibility of effective, therapeutic immunotherapy.
Mount Sinai School of Medicine 1 Gustave L Levy Place, New York, NY 10029 USA.
Donna M
DM
Tscherne
Adolfo
A
García-Sastre